RAXVID
LIVE

Serial Number

99225404

Owner

Pfizer Inc.

Attorney

Yana Gorbach

Filing Date

Jun 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RAXVID Trademark

Serial Number: 99225404

RAXVID is a trademark filed by Pfizer Inc. on June 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Pfizer Inc. (3 trademarks)

66 Hudson Boulevard East
New York, NY 10001-2192

Entity Type: 03

Trademark Details

Filing Date

June 9, 2025

Registration Date

Not Registered

Published for Opposition

October 7, 2025

Goods & Services

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 30, 2026 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 30, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 30, 2026 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 2, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2025 CNSA
ASSIGNED TO EXAMINER
Sep 8, 2025 DOCK
ASSIGNED TO EXAMINER
Sep 4, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 9, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2025 NWOS
NEW APPLICATION ENTERED
Jun 9, 2025 NWAP